Project Details
| Status | Finished |
|---|---|
| Effective start/end date | 1/1/00 → 1/1/00 |
Funding
- Novartis Pharmaceuticals Corporation: $13,942.31
A randomized, double-blind, parallel group, placebo controlled, multicenter phase 3 trial to evaluate the efficacy, safety and tolerability of ianalumab on top of standard-of-care therapy in patients with active lupus nephritis
- Kochar, Tina (PI)
Project: Other project